Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models.

Source:http://linkedlifedata.com/resource/pubmed/id/20038714

Download in:

View as

General Info

PMID
20038714